×

Navigation

Facts

  • Vicodin is a pharmaceutical drug which is a combination of two pain relievers; acetaminophen, commonly known as Tylenol; and hydrocodone, synthetic codeine.
  • Recreational users of Adderall are typically taking much larger doses than would normally be prescribed which puts them at risk of overdose.
  • Magic mushrooms contain around 0.2 to 0.4 percent of the hallucinogen psilocybin, along with a trace amount of psilocin; another hallucinogenic substance.
  • Over 2 million people are currently using cocaine in the U.S.

GET HELP LOCATING A DRUG TREATMENT PROGRAM

Phone Email
Residential Long-Term Treatment (More Than 30 Days) - Willingboro

Going to and completing a residential long-term rehab (more than 30 days) program in Willingboro is often the cornerstone in an addict's successful recovery from their individual struggles with drug or alcohol addiction. This variety of drug rehabilitation is far more intensive than others mainly because the client lives at the facility full-time through the treatment process. While many addicts are initially hesitant about attending a long-term program lasting longer than 30 days they soon understand the fantastic benefit. A residential long-term treatment (more than 30 days) program provides the recovering individual the time to thoroughly withdrawal from drugs and concentrate on themselves. Shorter programs are not capable of this due to their short duration.

  • Libertae Inc
    6 miles from Willingboro, New Jersey
    Libertae Inc is located at:

    5245 Bensalem Boulevard
    Bensalem, PA. 19020

    If you would like to contact Libertae Inc, you can reach them at 215-639-8681 x210.

    Libertae Inc offers the following treatment services: Substance Abuse Treatment Services, Halfway House, Residential Long-Term Treatment (More Than 30 Days), Persons With Co-Occurring Mental And Substance Abuse Disorders, Persons With Hiv/Aids, Gays And Lesbians, Pregnant/Postpartum Women, Women, Criminal Justice Clients
    Payment forms accepted: Self Payment, Medicaid